Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The study frames CLEAR as a foundation model, suggesting it can learn generalizable representations from broad radiology data and then be adapted for specific tasks
The obesity approval (Zepbound) followed in November 2023
By targeting the root causes of metabolic dysfunction, it offers more than temporary weight loss
Additionally, advancements in drug delivery technologies are enhancing the bioavailability and efficacy of oral GLP-1 therapies, further fueling their market growth
This is their mechanism for weight loss
US$ 20.85
US$ 23.47
US$ 25.64
US$ 20.66
US$ 21.77
US$ 22.48
US$ 26.29
US$ 26.81
US$ 21.12
US$ 26.90
